Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros ...
12:00am, Monday, 03'rd Feb 2020Stocks That Hit 52-Week Lows On Friday
04:00pm, Friday, 31'st Jan 2020
Friday's morning session saw 167 companies set new 52-week lows.
Facts of Interest:
The largest company in terms of market cap to set a new 52-week low was Xperi (...
Omeros (NASDAQ:OMER) and Johnson & Johnson (NASDAQ:JNJ) Financial Contrast
07:32am, Thursday, 30'th Jan 2020
Omeros (NASDAQ:OMER) and Johnson & Johnson (NYSE:JNJ) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ow
Obsessive-Compulsive Disorder Therapeutic Landscape & Pipeline Review (2020, H1)
08:30pm, Friday, 24'th Jan 2020
The "Obsessive-Compulsive Disorder - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
Obsessive-Compulsive Disorder - Pipeline Review, H1 2020
12:08pm, Friday, 24'th Jan 2020
Dublin, Jan. 24, 2020 -- The "Obsessive-Compulsive Disorder - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.This.
Omeros seeks accelerated approval from FDA for new drug
10:30pm, Thursday, 23'rd Jan 2020
Seattle biotech company Omeros Corp. is seeking accelerated approval from the Federal Drug Administration for its drug that aims to fight a life-threatening disorder that can develop after receiving a
Omeros (NASDAQ:OMER) Upgraded to "Sell" by BidaskClub
08:30am, Tuesday, 21'st Jan 2020
BidaskClub upgraded shares of Omeros (NASDAQ:OMER) from a strong sell rating to a sell rating in a research note released on Friday, BidAskClub reports. A number of other equities analysts have also w
So far Monday, January 20, NASDAQ is down -3.65% and the S&P is up 0.25%. Let’s take a look at
So far Sunday, January 19, NASDAQ is down -3.65% and the S&P is up 0.25%. Let’s take a look at
So far Saturday, January 18, NASDAQ is down -3.65% and the S&P is up 0.25%. Here are this morning’s most
What Kind Of Shareholder Owns Most Omeros Corporation (NASDAQ:OMER) Stock?
04:46pm, Tuesday, 14'th Jan 2020
A look at the shareholders of Omeros Corporation (NASDAQ:OMER) can tell us which group is most powerful. Institutions...
Omeros Co. (NASDAQ:OMER) Expected to Announce Quarterly Sales of $31.38 Million
07:32am, Saturday, 11'th Jan 2020
Equities research analysts forecast that Omeros Co. (NASDAQ:OMER) will report sales of $31.38 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estima
2019 Glomerulonephritis Pipeline Review, H2 - Biogen Inc, Omeros Corp, Pfizer Inc & Visterra Inc - ResearchAndMarkets.com
09:57am, Thursday, 09'th Jan 2020
DUBLIN--(BUSINESS WIRE)--The "Glomerulonephritis - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Glomerulonephritis is also known as glomerular nephriti
Hedge Funds Aren’t Crazy About Omeros Corporation (OMER) Anymore
10:16pm, Friday, 20'th Dec 2019
Last year's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P; 500 fell by about 4.8% during 2018 a
myTomorrows and Omeros Corporation Collaborate to Provide an Expanded Access Program for Narsoplimab
01:30pm, Wednesday, 18'th Dec 2019
AMSTERDAM & SEATTLE--(BUSINESS WIRE)--myTomorrows, a global health technology company, and Omeros Corporation (Nasdaq: OMER), an innovative biopharmaceutical company committed to discovering, developi
